Comprehensive Research Report: CD14 Gene (UniProt P08571) Falcon Edison Scientific Literature 17 citations 2 artifacts 2026-09-30T06:16:55.945850

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Comprehensive Research Report: CD14 Gene (UniProt P08571)

Gene Identity and Protein Structure

CD14 encodes the monocyte differentiation antigen CD14, a pattern recognition receptor that serves as a critical component of the innate immune system (sharygin2023roleofcd14 pages 1-3). The protein is a glycosylphosphatidylinositol (GPI)-anchored cell surface glycoprotein characterized by a distinctive structural architecture (sharygin2023roleofcd14 pages 1-3, vasudevan2022atlr4independentcritical pages 1-3). Structurally, CD14 forms a bent solenoid composed of thirteen β-strands, with eleven strands overlapping with leucine-rich repeat (LRR) regions (sharygin2023roleofcd14 pages 1-3). The overall structure includes eleven parallel and two antiparallel β-strands that form a concave ligand-binding surface (sharygin2023roleofcd14 pages 1-3). The N-terminal binding pocket contains hydrophobic residues and charged residues around its rim, features that accommodate ligands and orient phosphate groups in bacterial lipopolysaccharide (LPS) (sharygin2023roleofcd14 pages 1-3, sharygin2023roleofcd14 pages 8-9). Disulfide bonds and N-linked glycosylation sites near the N-terminal β-strands are critical for proper protein folding and signaling function (sharygin2023roleofcd14 pages 1-3).

CD14 exists in two biologically active forms: membrane-bound CD14 (mCD14) and soluble CD14 (sCD14) (sharygin2023roleofcd14 pages 1-3, ciesielska2021tlr4andcd14 pages 2-4). Membrane-bound CD14 is attached to the cell surface through a GPI anchor rather than a conventional transmembrane domain (sharygin2023roleofcd14 pages 1-3, sharygin2023roleofcd14 pages 3-4). Soluble CD14 lacks the GPI anchor and circulates in serum, where it can enable LPS responses in cells that do not express membrane-bound CD14, including epithelial and endothelial cells (sharygin2023roleofcd14 pages 1-3, ciesielska2021tlr4andcd14 pages 2-4). In immune cells, sCD14 can arise through proteolytic cleavage of membrane CD14 or through proteolysis-independent pathways (ciesielska2021tlr4andcd14 pages 2-4). The liver produces sCD14 as an acute-phase response protein during chronic inflammatory disease (sharygin2023roleofcd14 pages 1-3).

Primary Molecular Function and Ligand Specificity

The primary molecular function of CD14 is to serve as a co-receptor that captures, concentrates, and transfers pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) to downstream signaling receptors, particularly the Toll-like receptor 4 (TLR4)/MD-2 complex (vasudevan2022atlr4independentcritical pages 1-3, ciesielska2021tlr4andcd14 pages 1-2, sharygin2023roleofcd14 pages 3-4). CD14's best-characterized ligand is bacterial lipopolysaccharide (endotoxin), the major component of Gram-negative bacterial outer membranes (vasudevan2022atlr4independentcritical pages 1-3, sharygin2023roleofcd14 pages 3-4).

The molecular mechanism of LPS recognition involves a sequential transfer cascade. LPS-binding protein (LBP), a serum protein, first binds LPS aggregates or bacterial membranes and facilitates extraction of individual LPS monomers (gauthier2022lipopolysaccharidedetectionby pages 4-5, ciesielska2021tlr4andcd14 pages 2-4, gauthier2022lipopolysaccharidedetectionby pages 3-4). LBP then transfers the LPS monomer to CD14, which can be either membrane-bound or soluble (gauthier2022lipopolysaccharidedetectionby pages 4-5, ciesielska2021tlr4andcd14 pages 2-4, fitzgerald2020tolllikereceptorsand pages 3-4). CD14 captures the LPS monomer in its N-terminal hydrophobic pocket, which accommodates most of the endotoxin's acyl chains (ciesielska2021tlr4andcd14 pages 4-5). CD14 subsequently transfers or presents LPS to the TLR4-MD-2 receptor complex (gauthier2022lipopolysaccharidedetectionby pages 4-5, gauthier2022lipopolysaccharidedetectionby pages 3-4, fitzgerald2020tolllikereceptorsand pages 3-4). This delivery promotes TLR4 dimerization, as the lipid A acyl chains of LPS engage hydrophobic regions in MD-2 and make contacts involving two TLR4-MD-2 heterodimers, stabilizing the activated receptor arrangement (gauthier2022lipopolysaccharidedetectionby pages 3-4, fitzgerald2020tolllikereceptorsand pages 3-4, ciesielska2021tlr4andcd14 pages 4-5).

Beyond LPS, CD14 recognizes a broad spectrum of microbial and endogenous ligands, establishing it as a versatile pattern recognition molecule (sharygin2023roleofcd14 pages 14-16, ciesielska2021tlr4andcd14 pages 14-15). CD14 binds peptidoglycan and lipoteichoic acid from bacterial cell walls (sharygin2023roleofcd14 pages 14-16, ciesielska2021tlr4andcd14 pages 14-15, behzadi2021tolllikereceptorsgeneral pages 18-19), CpG-rich DNA (sharygin2023roleofcd14 pages 14-16, ciesielska2021tlr4andcd14 pages 14-15), and various phospholipids (ciesielska2021tlr4andcd14 pages 14-15). Among damage-associated molecular patterns, CD14 recognizes oxidized phospholipids (particularly oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine, oxPAPC) (sharygin2023roleofcd14 pages 14-16, sharygin2023roleofcd14 pages 3-4), S100A9 (sharygin2023roleofcd14 pages 14-16), mitochondrial DNA (sharygin2023roleofcd14 pages 14-16), heat-shock proteins (sharygin2023roleofcd14 pages 14-16), fibronectin (sharygin2023roleofcd14 pages 14-16), biglycan (sharygin2023roleofcd14 pages 14-16, sharygin2023roleofcd14 pages 1-3), and β-amyloid aggregates (ciesielska2021tlr4andcd14 pages 14-15, sharygin2023roleofcd14 pages 10-12). This broad ligand repertoire allows CD14 to influence multiple pattern recognition receptors beyond TLR4, extending its function across diverse inflammatory contexts (ciesielska2021tlr4andcd14 pages 14-15).

Ligand / cargo Classification Origin CD14-related biological significance Evidence
Lipopolysaccharide (LPS; endotoxin) PAMP Outer membrane of Gram-negative bacteria Principal and best-characterized CD14 ligand. LBP extracts an LPS monomer and transfers it to membrane or soluble CD14; CD14 then presents it to TLR4–MD-2, promoting TLR4 dimerization, inflammatory signaling, and receptor endocytosis. CD14 can also facilitate cytosolic LPS delivery for noncanonical inflammasome activation. (gauthier2022lipopolysaccharidedetectionby pages 4-5, fitzgerald2020tolllikereceptorsand pages 3-4, vasudevan2022atlr4independentcritical pages 5-7)
Peptidoglycan PAMP Bacterial cell wall Directly binds CD14 and supports recognition or presentation of bacterial cell-wall material to pattern-recognition pathways; the precise downstream receptor and response depend on cellular context. (sharygin2023roleofcd14 pages 14-16, ciesielska2021tlr4andcd14 pages 14-15, behzadi2021tolllikereceptorsgeneral pages 18-19)
Lipoteichoic acid (LTA) PAMP Cell wall of Gram-positive bacteria CD14 captures or presents LTA and can facilitate TLR2-associated inflammatory responses, extending its function beyond the LPS–TLR4 system. (sharygin2023roleofcd14 pages 14-16, ciesielska2021tlr4andcd14 pages 14-15, sharygin2023roleofcd14 pages 1-3)
CpG-rich microbial DNA PAMP Unmethylated CpG motifs enriched in bacterial and viral DNA Reported CD14 ligand/cargo that may facilitate nucleic-acid uptake or presentation to endosomal pattern-recognition receptors, including TLR9. (sharygin2023roleofcd14 pages 14-16, ciesielska2021tlr4andcd14 pages 14-15, behzadi2021tolllikereceptorsgeneral pages 18-19)
Double-stranded RNA / poly(I:C)-like RNA PAMP or experimental PAMP mimic Viral replication intermediates or synthetic dsRNA analogues Listed among CD14-associated microbial ligands; may support uptake and delivery to intracellular RNA-sensing pathways, although direct binding and pathway dependence are less firmly characterized than for LPS. (sharygin2023roleofcd14 pages 14-16)
Microbial phospholipids and lipoprotein-related ligands PAMP Bacterial membranes Broadens CD14-mediated recognition of microbial membrane material and can facilitate signaling through CD14-dependent TLR systems, including TLR2-family complexes. (ciesielska2021tlr4andcd14 pages 14-15, sharygin2023roleofcd14 pages 1-3)
Oxidized phospholipids, especially oxPAPC DAMP Oxidation of host membrane phospholipids during tissue injury, oxidative stress, atherosclerosis, or inflammation CD14 binds and internalizes oxPAPC. This can promote TLR-independent NLRP3 inflammasome activation and IL-1β/IL-18 release, sometimes without cell death. (sharygin2023roleofcd14 pages 3-4, sharygin2023roleofcd14 pages 14-16)
S100A9 DAMP / alarmin Released or extracellularly accumulated during myeloid-cell activation, tissue damage, and inflammation Reported endogenous CD14-recognized signal that can connect sterile injury to innate inflammatory signaling; the exact CD14-dependent pathway varies by context. (sharygin2023roleofcd14 pages 14-16)
Mitochondrial DNA DAMP Released from damaged or dying host cells and disrupted mitochondria Reported CD14-associated damage signal; may facilitate uptake or presentation of mitochondrial nucleic acids to intracellular innate sensors, linking cellular injury to inflammation. (sharygin2023roleofcd14 pages 14-16)
Heat-shock proteins DAMP / alarmin Released or exposed during cellular stress, necrosis, or tissue injury Reported CD14 ligands that may enhance recognition of stressed or damaged tissue and modulate TLR-associated inflammatory responses. (sharygin2023roleofcd14 pages 14-16)
Fibronectin DAMP / extracellular-matrix signal Extracellular matrix, particularly fragments or altered forms generated during tissue damage and remodeling Reported CD14-recognized endogenous signal that may couple matrix injury or remodeling to innate immune activation. (sharygin2023roleofcd14 pages 14-16)
Biglycan DAMP / extracellular-matrix proteoglycan Extracellular matrix; soluble biglycan can be released during tissue injury or remodeling Interacts with CD14 and can participate in TLR2- or TLR4-associated sterile inflammatory signaling. (sharygin2023roleofcd14 pages 14-16, sharygin2023roleofcd14 pages 1-3)
β-Amyloid DAMP / aggregated host peptide Aggregates derived from amyloid precursor protein, particularly in neurodegenerative tissue CD14 binds or captures β-amyloid and contributes to its uptake by microglia and other myeloid cells, potentially affecting both aggregate clearance and neuroinflammatory signaling. (ciesielska2021tlr4andcd14 pages 14-15, sharygin2023roleofcd14 pages 10-12)

Table: This table distinguishes CD14’s best-established microbial ligand, LPS, from additional reported PAMPs and endogenous DAMPs. Because CD14 is a nonenzymatic capture, transfer, and trafficking co-receptor, these molecules are more accurately described as ligands or cargoes rather than catalytic substrates.

Subcellular Localization and Trafficking

CD14 exhibits a dynamic subcellular distribution that is central to its regulatory functions. At the cell surface, membrane-bound CD14 is enriched in sphingolipid- and cholesterol-rich membrane nanodomains known as lipid rafts (matveichuk2024flotillinsaffectlpsinduced pages 1-2, sharygin2023roleofcd14 pages 12-14, sharygin2023roleofcd14 pages 3-4, ciesielska2021tlr4andcd14 pages 2-4). This lipid raft localization is critical for efficient LPS presentation to TLR4-MD-2 and for initiating downstream signaling events (sharygin2023roleofcd14 pages 12-14, sharygin2023roleofcd14 pages 3-4).

CD14 undergoes constitutive endocytosis in resting cells, and this internalization is accelerated following LPS stimulation (matveichuk2024flotillinsaffectlpsinduced pages 1-2, ciesielska2021tlr4andcd14 pages 14-15). Following ligand engagement, CD14 facilitates internalization of the TLR4/MD-2 complex from the plasma membrane into early endosomes (ciesielska2021tlr4andcd14 pages 5-7, matveichuk2024flotillinsaffectlpsinduced pages 1-2). This CD14-dependent endocytosis is essential for the spatial regulation of TLR4 signaling: it terminates plasma membrane-associated MyD88-dependent signaling while enabling endosomal TRIF-dependent signaling (ciesielska2021tlr4andcd14 pages 5-7, ciesielska2021tlr4andcd14 pages 2-4). In cells lacking CD14, such as murine splenic B lymphocytes, TLR4 does not undergo LPS-induced endocytosis, and TRIF-dependent responses are selectively impaired (ciesielska2021tlr4andcd14 pages 5-7).

Internalized CD14 traffics through multiple intracellular compartments. It localizes to EEA1-positive early endosomes and can be delivered to lysosomes for degradation (matveichuk2024flotillinsaffectlpsinduced pages 1-2, matveichuk2024flotillinsaffectlpsinduced pages 17-20). CD14 also recycles through Rab11-positive recycling endosomes and the trans-Golgi network (marked by golgin-97), returning to the plasma membrane to maintain the functional cell-surface pool (matveichuk2024flotillinsaffectlpsinduced pages 1-2, matveichuk2024flotillinsaffectlpsinduced pages 17-20). Depletion of flotillin scaffolding proteins alters CD14 trafficking, causing its accumulation in early endosomes and the trans-Golgi network while reducing its abundance in recycling endosomes and at the cell surface (matveichuk2024flotillinsaffectlpsinduced pages 17-20). This trafficking dysregulation also enhances CD14 shedding, generating soluble CD14 that can continue to transfer LPS to TLR4-MD-2 (matveichuk2024flotillinsaffectlpsinduced pages 17-20).

Soluble CD14 circulates in serum and other body fluids, where it acts on cells that express low or absent membrane CD14, including epithelial cells, endothelial cells, and hepatocytes (sharygin2023roleofcd14 pages 1-3, sharygin2023roleofcd14 pages 3-4). This enables CD14-mediated immune responses beyond classical immune cell populations (sharygin2023roleofcd14 pages 1-3).

Signaling Pathways and Biochemical Processes

CD14 initiates or regulates multiple distinct signaling pathways, reflecting its roles as both a TLR4 co-receptor and an independent trafficking and signaling molecule.

MyD88-Dependent TLR4 Pathway

At the plasma membrane, CD14-mediated delivery of LPS to TLR4-MD-2 initiates the MyD88-dependent signaling pathway (stierschneider2023sheddinglighton pages 2-4, sharygin2023roleofcd14 pages 3-4, ciesielska2021tlr4andcd14 pages 2-4). Following TLR4 dimerization, the adaptor proteins TIRAP (also known as MAL) and MyD88 are recruited to the receptor's intracellular TIR domains (stierschneider2023sheddinglighton pages 2-4, sharygin2023roleofcd14 pages 3-4, ciesielska2021tlr4andcd14 pages 4-5). MyD88 recruits IRAK4, IRAK1, and IRAK2 to form the myddosome signaling complex (stierschneider2023sheddinglighton pages 2-4, sharygin2023roleofcd14 pages 3-4, ciesielska2021tlr4andcd14 pages 4-5). This assembly activates TRAF6 and the TAK1 kinase complex, which in turn activates the IKK complex (leading to NF-κB nuclear translocation) and MAPK cascades (stierschneider2023sheddinglighton pages 2-4, ciesielska2021tlr4andcd14 pages 4-5, duan2022tolllikereceptorsignaling pages 2-3). The resulting transcriptional program induces early expression of pro-inflammatory cytokines including TNF-α, IL-1β, IL-6, and COX-2, as well as chemokines and other inflammatory mediators (stierschneider2023sheddinglighton pages 2-4, sharygin2023roleofcd14 pages 3-4, ciesielska2021tlr4andcd14 pages 4-5).

TRIF-Dependent TLR4 Pathway

CD14-mediated internalization of the activated TLR4-MD-2 complex transitions signaling from the plasma membrane MyD88-dependent phase to the endosomal TRIF-dependent phase (ciesielska2021tlr4andcd14 pages 5-7, ciesielska2021tlr4andcd14 pages 2-4, ciesielska2021tlr4andcd14 pages 4-5). Within endosomes, the adaptor protein TRAM recruits TRIF to TLR4 (stierschneider2023sheddinglighton pages 2-4, ciesielska2021tlr4andcd14 pages 4-5). TRIF activates two parallel branches: one involving TRAF3, TBK1, and IKKε, which phosphorylate and activate IRF3 to induce type I interferons (IFN-β) and interferon-stimulated genes such as CCL5/RANTES and CXCL10 (stierschneider2023sheddinglighton pages 2-4, ciesielska2021tlr4andcd14 pages 5-7, ciesielska2021tlr4andcd14 pages 4-5); and another involving TRAF6 or RIPK1, which activates a late phase of NF-κB and MAPK signaling (ciesielska2021tlr4andcd14 pages 4-5, duan2022tolllikereceptorsignaling pages 2-3). This endosomal signaling phase contributes to both interferon responses and a second wave of inflammatory cytokine production (ciesielska2021tlr4andcd14 pages 5-7, ciesielska2021tlr4andcd14 pages 4-5). Subsequent endosome maturation and lysosomal delivery of TLR4 help terminate inflammatory signaling (ciesielska2021tlr4andcd14 pages 2-4).

TLR4-Independent NFAT Signaling

CD14 can activate the transcription factor NFAT independently of TLR4 (sharygin2023roleofcd14 pages 12-14, sharygin2023roleofcd14 pages 3-4). When LPS binds CD14 in lipid rafts, CD14 recruits Src-family kinases and PLCγ2, leading to calcium mobilization, calcineurin activation, and NFAT dephosphorylation and nuclear translocation (sharygin2023roleofcd14 pages 12-14, sharygin2023roleofcd14 pages 3-4). In dendritic cells, this pathway promotes expression of pro-apoptotic genes and contributes to immune tolerance and self-regulation (sharygin2023roleofcd14 pages 12-14). This mechanism demonstrates that CD14 can initiate signaling even though it lacks an intracellular signaling domain, by recruiting adaptor proteins and kinases to lipid raft microdomains (sharygin2023roleofcd14 pages 12-14).

Noncanonical Inflammasome and Intracellular LPS Sensing

A major recent advance in CD14 biology, reported by Vasudevan et al. (2022), established that CD14 has a critical TLR4-independent function in intracellular LPS sensing (vasudevan2022atlr4independentcritical pages 5-7, vasudevan2022atlr4independentcritical pages 1-3, vasudevan2022atlr4independentcritical pages 3-5). CD14 promotes the internalization and cytosolic delivery of extracellular LPS, enabling LPS to activate the noncanonical inflammasome pathway (vasudevan2022atlr4independentcritical pages 5-7, vasudevan2022atlr4independentcritical pages 1-3, vasudevan2022atlr4independentcritical pages 3-5). In the cytosol, LPS directly binds inflammatory caspases—caspase-11 in mice and the analogous caspases-4 and -5 in humans—causing their oligomerization (vasudevan2022atlr4independentcritical pages 1-3, vasudevan2022atlr4independentcritical pages 3-5). Activated inflammatory caspases cleave gasdermin D (GSDMD), generating GSDMD-N fragments that form membrane pores, leading to pyroptotic cell death, alarmin release, and inflammatory pathology including endotoxic shock (vasudevan2022atlr4independentcritical pages 5-7, vasudevan2022atlr4independentcritical pages 1-3, vasudevan2022atlr4independentcritical pages 3-5). Genetic studies in Cd14−/− and Tlr4−/−Cd14−/− mice demonstrated that this function is separable from CD14's role in TLR4 signaling (vasudevan2022atlr4independentcritical pages 5-7, vasudevan2022atlr4independentcritical pages 3-5). The mechanism involves CD14-dependent LPS uptake followed by endolysosomal membrane permeabilization, which allows LPS to escape into the cytosol (vasudevan2022atlr4independentcritical pages 5-7). This pathway also secondarily activates the NLRP3 inflammasome through potassium efflux resulting from GSDMD pore formation, leading to caspase-1 activation and processing of IL-1β and IL-18 (vasudevan2022atlr4independentcritical pages 1-3).

NLRP3 Inflammasome Priming and Activation

CD14 contributes to NLRP3 inflammasome responses through multiple mechanisms (sharygin2023roleofcd14 pages 14-16, sharygin2023roleofcd14 pages 12-14, ciesielska2021tlr4andcd14 pages 4-5). First, CD14-mediated TLR4 signaling provides the priming signal: MyD88-dependent NF-κB activation induces transcription of NLRP3 and pro-IL-1β and promotes posttranslational modifications of NLRP3 that prepare it for activation (ciesielska2021tlr4andcd14 pages 4-5). Second, CD14 endocytosis can directly promote NLRP3 inflammasome assembly independently of TLRs (sharygin2023roleofcd14 pages 14-16, sharygin2023roleofcd14 pages 12-14). In human monocytes, epithelial cells, and keratinocytes responding to LPS or oxidized phospholipids (oxPAPC), CD14 internalization enables NLRP3 activation and IL-1β/IL-18 release, sometimes without inducing cell death (sharygin2023roleofcd14 pages 14-16, sharygin2023roleofcd14 pages 3-4, sharygin2023roleofcd14 pages 12-14). This distinguishes CD14-driven NLRP3 responses from the pyroptotic noncanonical inflammasome pathway (sharygin2023roleofcd14 pages 14-16, sharygin2023roleofcd14 pages 3-4).

Pathway category Initiation and CD14 role Key signaling molecules Transcription factors / effectors Principal cytokine or cellular outcomes Evidence
MyD88-dependent TLR4 signaling LBP extracts LPS monomers; CD14 captures and transfers LPS to TLR4–MD-2, promoting receptor dimerization and signaling at the plasma membrane TLR4–MD-2 → TIRAP/MAL → MyD88 → IRAK4 and IRAK1/2 → TRAF6 → TAK1 → IKK complex and MAPKs NF-κB, AP-1, CREB; ERK, JNK and p38 activation Early expression of TNF, IL-6, pro-IL-1β, COX-2 and other inflammatory mediators; also supplies transcriptional priming for NLRP3 inflammasome responses (stierschneider2023sheddinglighton pages 2-4, ciesielska2021tlr4andcd14 pages 4-5, gauthier2022lipopolysaccharidedetectionby pages 4-5)
TRIF-dependent TLR4 signaling CD14 drives internalization of activated TLR4–MD-2 from the plasma membrane into endosomes, switching signaling from the surface MyD88 phase to the endosomal TRIF phase TRAM → TRIF → TRAF3 → TBK1/IKKε; parallel TRIF–TRAF6/RIPK1–TAK1 signaling IRF3, late NF-κB and MAPKs Type I interferons, CCL5/RANTES, CXCL10 and a later wave of inflammatory gene expression; subsequent receptor trafficking and degradation help terminate signaling (stierschneider2023sheddinglighton pages 2-4, ciesielska2021tlr4andcd14 pages 5-7, ciesielska2021tlr4andcd14 pages 4-5)
TLR4-independent NFAT pathway LPS-bound CD14 clusters in lipid rafts and initiates signaling despite lacking a cytoplasmic domain Src-family kinases → ITAM-associated adaptors/Syk → PLCγ2 → Ca²⁺–calcineurin NFAT NFAT nuclear translocation and context-dependent pro-apoptotic or tolerance-associated gene expression, particularly in dendritic cells (sharygin2023roleofcd14 pages 12-14, sharygin2023roleofcd14 pages 3-4)
TLR4-independent noncanonical inflammasome CD14 internalizes extracellular LPS and promotes its endosomal-to-cytosolic delivery; direct cytosolic delivery bypasses the requirement for CD14 Caspase-11 in mice; analogous inflammatory caspases-4/5 in humans → gasdermin D Gasdermin-D pore formation; secondary NLRP3–caspase-1 activation Pyroptosis, alarmin release, IL-1β and IL-18 maturation, vascular coagulopathy and endotoxic-shock pathology; this mechanism is strongly supported genetically in mouse models (vasudevan2022atlr4independentcritical pages 5-7, vasudevan2022atlr4independentcritical pages 1-3, vasudevan2022atlr4independentcritical pages 3-5)
NLRP3 inflammasome-associated signaling CD14 supports at least two stages: efficient LPS–TLR4 priming of NLRP3 and pro-IL-1β, and ligand endocytosis that can promote inflammasome activation; noncanonical caspase activation can engage NLRP3 secondarily TLR4–NF-κB priming; NLRP3 → ASC → caspase-1; or caspase-11/4/5 → gasdermin D → K⁺ efflux → NLRP3 Caspase-1 is the principal cytokine-processing effector rather than a transcription factor Processing and secretion of IL-1β and IL-18, with or without pyroptotic death depending on ligand and cellular context; CD14 is a facilitator, not a structural inflammasome subunit (sharygin2023roleofcd14 pages 14-16, vasudevan2022atlr4independentcritical pages 1-3, sharygin2023roleofcd14 pages 12-14, ciesielska2021tlr4andcd14 pages 4-5)

Table: This table maps CD14-mediated ligand delivery and trafficking to canonical TLR4 and TLR4-independent signaling outputs. It distinguishes plasma-membrane MyD88 signaling, endosomal TRIF signaling, NFAT activation, and canonical versus noncanonical inflammasome responses.

Cellular and Tissue Expression

CD14 is primarily expressed in cells of the myeloid lineage, where it serves as a monocyte differentiation marker (sharygin2023roleofcd14 pages 1-3, ciesielska2021tlr4andcd14 pages 20-21). Its highest expression is found in monocytes and macrophages, which utilize CD14 for pathogen recognition and inflammatory activation (sharygin2023roleofcd14 pages 1-3, sharygin2023roleofcd14 pages 6-8). Within the monocyte compartment, the three major human subsets—classical (CD14++CD16−), intermediate (CD14++CD16+), and non-classical (CD14+CD16++)—are defined in part by their differential CD14 expression levels (sharygin2023roleofcd14 pages 1-3, sharygin2023roleofcd14 pages 9-10). CD14 is also expressed by dendritic cells, neutrophils, and at lower levels by B cells and T cells (sharygin2023roleofcd14 pages 1-3, sharygin2023roleofcd14 pages 6-8, sharygin2023roleofcd14 pages 3-4). In the liver, resident Kupffer cells (liver macrophages) express CD14 (sharygin2023roleofcd14 pages 1-3).

Beyond immune cells, CD14 expression has been documented in diverse non-immune cell types and tissues (sharygin2023roleofcd14 pages 1-3, sharygin2023roleofcd14 pages 6-8, sharygin2023roleofcd14 pages 14-16). In the intestine, enterocytes and intestinal epithelial cells express CD14 and can produce soluble CD14 (sharygin2023roleofcd14 pages 1-3, sharygin2023roleofcd14 pages 6-8, ciesielska2021tlr4andcd14 pages 20-21). Hepatocytes, both human and mouse, express CD14 mRNA and protein (sharygin2023roleofcd14 pages 1-3, sharygin2023roleofcd14 pages 6-8). Pancreatic islet beta cells also express CD14 (sharygin2023roleofcd14 pages 1-3). Endothelial cells and keratinocytes (skin epithelial cells) can respond to CD14-mediated signals and participate in inflammasome activation during tissue damage (sharygin2023roleofcd14 pages 3-4, sharygin2023roleofcd14 pages 12-14, sharygin2023roleofcd14 pages 14-16). Soluble CD14 enables LPS responsiveness in many of these non-immune cell types that may express low levels of membrane CD14 (sharygin2023roleofcd14 pages 1-3, sharygin2023roleofcd14 pages 3-4).

In diseased tissues, CD14 expression is altered across multiple organ systems. Studies have documented CD14 dysregulation in hematopoietic, genitourinary, brain and nervous system, lung, digestive, musculoskeletal, liver, and vascular systems in conditions including nephritis, renal fibrosis, pneumonia, inflammatory bowel disease, liver injury, hepatic fibrosis, shock, and ischemia (sharygin2023roleofcd14 pages 14-16). In tumors, CD14-positive tumor-associated macrophages and circulating CD14+ monocyte populations are associated with cancer progression, inflammation, and immune modulation (sharygin2023roleofcd14 pages 10-12, sharygin2023roleofcd14 pages 9-10).

Biological Processes and Functional Context

CD14 plays essential roles in innate immunity, inflammation, and host defense against microbial pathogens. Its primary biological function is to enable rapid recognition of Gram-negative bacteria through LPS detection, initiating inflammatory responses that include cytokine production, leukocyte recruitment, and activation of adaptive immunity (vasudevan2022atlr4independentcritical pages 1-3, sharygin2023roleofcd14 pages 3-4, sharygin2023roleofcd14 pages 1-3). The sequential activation of MyD88-dependent and TRIF-dependent TLR4 pathways allows for both immediate inflammatory responses and subsequent interferon-mediated antiviral and antibacterial programs (ciesielska2021tlr4andcd14 pages 5-7, ciesielska2021tlr4andcd14 pages 2-4, ciesielska2021tlr4andcd14 pages 4-5).

CD14's ability to recognize diverse PAMPs and DAMPs positions it as a versatile sentinel for both infectious and sterile inflammatory challenges (sharygin2023roleofcd14 pages 14-16, ciesielska2021tlr4andcd14 pages 14-15, sharygin2023roleofcd14 pages 1-3). Through its interactions with lipoteichoic acid and peptidoglycan, CD14 can facilitate responses to Gram-positive bacteria (sharygin2023roleofcd14 pages 14-16, ciesielska2021tlr4andcd14 pages 14-15). Its recognition of oxidized phospholipids, heat-shock proteins, and extracellular matrix components links CD14 to sterile inflammation in atherosclerosis, tissue injury, and autoimmune diseases (sharygin2023roleofcd14 pages 14-16, sharygin2023roleofcd14 pages 1-3, sharygin2023roleofcd14 pages 3-4). The binding of β-amyloid by CD14 on microglia implicates it in neuroinflammation and Alzheimer's disease pathogenesis (ciesielska2021tlr4andcd14 pages 14-15, sharygin2023roleofcd14 pages 10-12).

CD14-mediated regulation of TLR4 trafficking controls the duration and magnitude of inflammatory responses (ciesielska2021tlr4andcd14 pages 2-4). By promoting receptor endocytosis and subsequent lysosomal degradation, CD14 helps terminate inflammatory signaling and prevent excessive or prolonged inflammation (ciesielska2021tlr4andcd14 pages 2-4). Conversely, dysregulation of CD14 function or expression can contribute to chronic inflammation, sepsis, autoimmune diseases, and inflammatory disorders (sharygin2023roleofcd14 pages 4-6, sharygin2023roleofcd14 pages 1-3).

Recent Developments and Current Understanding (2022-2024)

The most significant recent advance in CD14 biology is the discovery of its TLR4-independent role in intracellular LPS sensing and noncanonical inflammasome activation, published by Vasudevan et al. in Cell Reports (May 2022) (vasudevan2022atlr4independentcritical pages 5-7, vasudevan2022atlr4independentcritical pages 1-3, vasudevan2022atlr4independentcritical pages 3-5). This work fundamentally expanded the understanding of CD14 beyond its canonical function as a TLR4 co-receptor. Using genetic approaches in Cd14−/− and Tlr4−/−Cd14−/− mice, the study demonstrated that CD14 is required for cytosolic LPS localization and caspase-11-dependent pyroptosis, IL-1β secretion, and endotoxic shock, independently of TLR4 signaling (vasudevan2022atlr4independentcritical pages 5-7, vasudevan2022atlr4independentcritical pages 3-5). This addresses a long-standing question in inflammasome biology: how extracellular LPS, which cannot readily cross lipid bilayers, reaches cytosolic inflammatory caspases (vasudevan2022atlr4independentcritical pages 1-3). CD14 serves as a critical gateway, promoting LPS internalization and cytosolic delivery, likely through endolysosomal membrane permeabilization (vasudevan2022atlr4independentcritical pages 5-7).

A 2023 review by Sharygin et al. in Immunology comprehensively examined CD14's expanding roles in human disease beyond innate immunity (sharygin2023roleofcd14 pages 1-3, sharygin2023roleofcd14 pages 14-16). This review highlighted CD14 expression and function in non-immune cells, including epithelial and endothelial populations, and its involvement in metabolic regulation, atherosclerosis, neurodegeneration, and cancer (sharygin2023roleofcd14 pages 1-3, sharygin2023roleofcd14 pages 6-8). The review also catalogued CD14's diverse ligand repertoire, emphasizing its recognition of both microbial PAMPs and endogenous DAMPs, and discussed its therapeutic potential as a target for inflammatory and immune-related disorders (sharygin2023roleofcd14 pages 14-16, sharygin2023roleofcd14 pages 1-3).

Ciesielska et al. published a comprehensive review in Cellular and Molecular Life Sciences (2021, highly cited with 1797 citations) examining TLR4 and CD14 trafficking dynamics and their influence on LPS-induced inflammatory signaling (ciesielska2021tlr4andcd14 pages 1-2, ciesielska2021tlr4andcd14 pages 2-4). This work detailed the mechanisms by which CD14 controls TLR4 endocytosis and the spatial segregation of MyD88- versus TRIF-dependent signaling, establishing CD14 as a key regulator of receptor trafficking and signal compartmentalization (ciesielska2021tlr4andcd14 pages 5-7, ciesielska2021tlr4andcd14 pages 2-4).

Additional recent work (2023-2024) has explored CD14's roles in monocyte heterogeneity and differentiation, with studies examining how CD14 expression levels define monocyte subsets and how these subsets contribute to inflammation, tissue repair, and disease pathogenesis in conditions ranging from rheumatoid arthritis to cardiovascular disease, diabetes, and cancer (sharygin2023roleofcd14 pages 10-12, sharygin2023roleofcd14 pages 9-10). Studies using full-spectrum flow cytometry and single-cell RNA sequencing have provided increasingly detailed portraits of CD14-expressing cell populations and their functional states in health and disease (sharygin2023roleofcd14 pages 10-12).

Matveichuk et al. (2024) demonstrated that flotillin scaffolding proteins regulate CD14 trafficking, abundance, and function, showing that flotillin depletion reduces cell-surface CD14 levels, inhibits constitutive CD14 endocytosis, and impairs both MyD88-dependent and TRIF-dependent TLR4 signaling (matveichuk2024flotillinsaffectlpsinduced pages 1-2, matveichuk2024flotillinsaffectlpsinduced pages 17-20). This work further established the importance of membrane microdomains and trafficking machinery in controlling CD14-mediated inflammatory responses (matveichuk2024flotillinsaffectlpsinduced pages 1-2, matveichuk2024flotillinsaffectlpsinduced pages 17-20).

Summary and Conclusions

CD14 (gene CD14, UniProt P08571) is a GPI-anchored pattern recognition receptor with leucine-rich repeat domains that functions as a critical co-receptor and trafficking regulator in innate immunity. Its primary molecular function is to capture and transfer bacterial lipopolysaccharide from LPS-binding protein to the TLR4-MD-2 complex, initiating both MyD88-dependent and TRIF-dependent inflammatory signaling pathways. CD14 recognizes a broad spectrum of microbial and endogenous ligands, including peptidoglycan, lipoteichoic acid, oxidized phospholipids, and β-amyloid, positioning it as a versatile sentinel for infection and tissue damage.

CD14 exists in membrane-bound and soluble forms and exhibits dynamic subcellular trafficking between plasma membrane lipid rafts, endosomes, recycling compartments, and lysosomes. This trafficking is central to its function: CD14-mediated endocytosis of TLR4 transitions signaling from plasma membrane MyD88 pathways to endosomal TRIF pathways and ultimately terminates signaling through receptor degradation.

Recent discoveries have fundamentally expanded understanding of CD14 beyond its canonical TLR4 co-receptor role. CD14 has a TLR4-independent function in promoting intracellular LPS delivery and activating the noncanonical inflammasome through caspase-11, leading to pyroptosis and inflammatory pathology. CD14 also activates NFAT signaling independently of TLR4 and participates in NLRP3 inflammasome priming and activation through multiple mechanisms.

CD14 is expressed primarily in monocytes, macrophages, and dendritic cells, but also in diverse non-immune cells including hepatocytes, enterocytes, endothelial cells, and epithelial cells. Its dysregulation is implicated in sepsis, chronic inflammation, autoimmune diseases, atherosclerosis, neurodegeneration, and cancer, making it a potential therapeutic target for inflammatory and immune-related disorders.

References

  1. (sharygin2023roleofcd14 pages 1-3): Daniel Sharygin, Leonidas G. Koniaris, Clark Wells, Teresa A. Zimmers, and Tewfik Hamidi. Role of cd14 in human disease. Immunology, 169:260-270, Mar 2023. URL: https://doi.org/10.1111/imm.13634, doi:10.1111/imm.13634. This article has 168 citations and is from a peer-reviewed journal.

  2. (vasudevan2022atlr4independentcritical pages 1-3): Swathy O. Vasudevan, Ashley J. Russo, Puja Kumari, Sivapriya Kailasan Vanaja, and Vijay A. Rathinam. A tlr4-independent critical role for cd14 in intracellular lps sensing. Cell reports, 39:110755-110755, May 2022. URL: https://doi.org/10.1016/j.celrep.2022.110755, doi:10.1016/j.celrep.2022.110755. This article has 81 citations and is from a highest quality peer-reviewed journal.

  3. (sharygin2023roleofcd14 pages 8-9): Daniel Sharygin, Leonidas G. Koniaris, Clark Wells, Teresa A. Zimmers, and Tewfik Hamidi. Role of cd14 in human disease. Immunology, 169:260-270, Mar 2023. URL: https://doi.org/10.1111/imm.13634, doi:10.1111/imm.13634. This article has 168 citations and is from a peer-reviewed journal.

  4. (ciesielska2021tlr4andcd14 pages 2-4): Anna Ciesielska, Marta Matyjek, and Katarzyna Kwiatkowska. Tlr4 and cd14 trafficking and its influence on lps-induced pro-inflammatory signaling. Cellular and Molecular Life Sciences: CMLS, 78:1233-1261, Oct 2021. URL: https://doi.org/10.1007/s00018-020-03656-y, doi:10.1007/s00018-020-03656-y. This article has 1797 citations.

  5. (sharygin2023roleofcd14 pages 3-4): Daniel Sharygin, Leonidas G. Koniaris, Clark Wells, Teresa A. Zimmers, and Tewfik Hamidi. Role of cd14 in human disease. Immunology, 169:260-270, Mar 2023. URL: https://doi.org/10.1111/imm.13634, doi:10.1111/imm.13634. This article has 168 citations and is from a peer-reviewed journal.

  6. (ciesielska2021tlr4andcd14 pages 1-2): Anna Ciesielska, Marta Matyjek, and Katarzyna Kwiatkowska. Tlr4 and cd14 trafficking and its influence on lps-induced pro-inflammatory signaling. Cellular and Molecular Life Sciences: CMLS, 78:1233-1261, Oct 2021. URL: https://doi.org/10.1007/s00018-020-03656-y, doi:10.1007/s00018-020-03656-y. This article has 1797 citations.

  7. (gauthier2022lipopolysaccharidedetectionby pages 4-5): Anna E. Gauthier, Randi D. Rotjan, and Jonathan C. Kagan. Lipopolysaccharide detection by the innate immune system may be an uncommon defence strategy used in nature. Open Biology, Oct 2022. URL: https://doi.org/10.1098/rsob.220146, doi:10.1098/rsob.220146. This article has 99 citations and is from a peer-reviewed journal.

  8. (gauthier2022lipopolysaccharidedetectionby pages 3-4): Anna E. Gauthier, Randi D. Rotjan, and Jonathan C. Kagan. Lipopolysaccharide detection by the innate immune system may be an uncommon defence strategy used in nature. Open Biology, Oct 2022. URL: https://doi.org/10.1098/rsob.220146, doi:10.1098/rsob.220146. This article has 99 citations and is from a peer-reviewed journal.

  9. (fitzgerald2020tolllikereceptorsand pages 3-4): Katherine A. Fitzgerald and Jonathan C. Kagan. Toll-like receptors and the control of immunity. Cell, 180:1044-1066, Mar 2020. URL: https://doi.org/10.1016/j.cell.2020.02.041, doi:10.1016/j.cell.2020.02.041. This article has 2632 citations and is from a highest quality peer-reviewed journal.

  10. (ciesielska2021tlr4andcd14 pages 4-5): Anna Ciesielska, Marta Matyjek, and Katarzyna Kwiatkowska. Tlr4 and cd14 trafficking and its influence on lps-induced pro-inflammatory signaling. Cellular and Molecular Life Sciences: CMLS, 78:1233-1261, Oct 2021. URL: https://doi.org/10.1007/s00018-020-03656-y, doi:10.1007/s00018-020-03656-y. This article has 1797 citations.

  11. (sharygin2023roleofcd14 pages 14-16): Daniel Sharygin, Leonidas G. Koniaris, Clark Wells, Teresa A. Zimmers, and Tewfik Hamidi. Role of cd14 in human disease. Immunology, 169:260-270, Mar 2023. URL: https://doi.org/10.1111/imm.13634, doi:10.1111/imm.13634. This article has 168 citations and is from a peer-reviewed journal.

  12. (ciesielska2021tlr4andcd14 pages 14-15): Anna Ciesielska, Marta Matyjek, and Katarzyna Kwiatkowska. Tlr4 and cd14 trafficking and its influence on lps-induced pro-inflammatory signaling. Cellular and Molecular Life Sciences: CMLS, 78:1233-1261, Oct 2021. URL: https://doi.org/10.1007/s00018-020-03656-y, doi:10.1007/s00018-020-03656-y. This article has 1797 citations.

  13. (behzadi2021tolllikereceptorsgeneral pages 18-19): Payam Behzadi, Herney Andrés García-Perdomo, and Tomasz M. Karpiński. Toll-like receptors: general molecular and structural biology. Journal of Immunology Research, 2021:1-21, May 2021. URL: https://doi.org/10.1155/2021/9914854, doi:10.1155/2021/9914854. This article has 333 citations and is from a peer-reviewed journal.

  14. (sharygin2023roleofcd14 pages 10-12): Daniel Sharygin, Leonidas G. Koniaris, Clark Wells, Teresa A. Zimmers, and Tewfik Hamidi. Role of cd14 in human disease. Immunology, 169:260-270, Mar 2023. URL: https://doi.org/10.1111/imm.13634, doi:10.1111/imm.13634. This article has 168 citations and is from a peer-reviewed journal.

  15. (vasudevan2022atlr4independentcritical pages 5-7): Swathy O. Vasudevan, Ashley J. Russo, Puja Kumari, Sivapriya Kailasan Vanaja, and Vijay A. Rathinam. A tlr4-independent critical role for cd14 in intracellular lps sensing. Cell reports, 39:110755-110755, May 2022. URL: https://doi.org/10.1016/j.celrep.2022.110755, doi:10.1016/j.celrep.2022.110755. This article has 81 citations and is from a highest quality peer-reviewed journal.

  16. (matveichuk2024flotillinsaffectlpsinduced pages 1-2): Orest V. Matveichuk, Anna Ciesielska, Aneta Hromada-Judycka, Natalia Nowak, Ichrak Ben Amor, Gabriela Traczyk, and Katarzyna Kwiatkowska. Flotillins affect lps-induced tlr4 signaling by modulating the trafficking and abundance of cd14. Cellular and Molecular Life Sciences, Apr 2024. URL: https://doi.org/10.1007/s00018-024-05221-3, doi:10.1007/s00018-024-05221-3. This article has 17 citations and is from a domain leading peer-reviewed journal.

  17. (sharygin2023roleofcd14 pages 12-14): Daniel Sharygin, Leonidas G. Koniaris, Clark Wells, Teresa A. Zimmers, and Tewfik Hamidi. Role of cd14 in human disease. Immunology, 169:260-270, Mar 2023. URL: https://doi.org/10.1111/imm.13634, doi:10.1111/imm.13634. This article has 168 citations and is from a peer-reviewed journal.

  18. (ciesielska2021tlr4andcd14 pages 5-7): Anna Ciesielska, Marta Matyjek, and Katarzyna Kwiatkowska. Tlr4 and cd14 trafficking and its influence on lps-induced pro-inflammatory signaling. Cellular and Molecular Life Sciences: CMLS, 78:1233-1261, Oct 2021. URL: https://doi.org/10.1007/s00018-020-03656-y, doi:10.1007/s00018-020-03656-y. This article has 1797 citations.

  19. (matveichuk2024flotillinsaffectlpsinduced pages 17-20): Orest V. Matveichuk, Anna Ciesielska, Aneta Hromada-Judycka, Natalia Nowak, Ichrak Ben Amor, Gabriela Traczyk, and Katarzyna Kwiatkowska. Flotillins affect lps-induced tlr4 signaling by modulating the trafficking and abundance of cd14. Cellular and Molecular Life Sciences, Apr 2024. URL: https://doi.org/10.1007/s00018-024-05221-3, doi:10.1007/s00018-024-05221-3. This article has 17 citations and is from a domain leading peer-reviewed journal.

  20. (stierschneider2023sheddinglighton pages 2-4): Anna Stierschneider and Christoph Wiesner. Shedding light on the molecular and regulatory mechanisms of tlr4 signaling in endothelial cells under physiological and inflamed conditions. Frontiers in Immunology, Nov 2023. URL: https://doi.org/10.3389/fimmu.2023.1264889, doi:10.3389/fimmu.2023.1264889. This article has 79 citations and is from a peer-reviewed journal.

  21. (duan2022tolllikereceptorsignaling pages 2-3): Tianhao Duan, Yang Du, Changsheng Xing, Helen Y. Wang, and Rong-Fu Wang. Toll-like receptor signaling and its role in cell-mediated immunity. Frontiers in Immunology, Mar 2022. URL: https://doi.org/10.3389/fimmu.2022.812774, doi:10.3389/fimmu.2022.812774. This article has 1297 citations and is from a peer-reviewed journal.

  22. (vasudevan2022atlr4independentcritical pages 3-5): Swathy O. Vasudevan, Ashley J. Russo, Puja Kumari, Sivapriya Kailasan Vanaja, and Vijay A. Rathinam. A tlr4-independent critical role for cd14 in intracellular lps sensing. Cell reports, 39:110755-110755, May 2022. URL: https://doi.org/10.1016/j.celrep.2022.110755, doi:10.1016/j.celrep.2022.110755. This article has 81 citations and is from a highest quality peer-reviewed journal.

  23. (ciesielska2021tlr4andcd14 pages 20-21): Anna Ciesielska, Marta Matyjek, and Katarzyna Kwiatkowska. Tlr4 and cd14 trafficking and its influence on lps-induced pro-inflammatory signaling. Cellular and Molecular Life Sciences: CMLS, 78:1233-1261, Oct 2021. URL: https://doi.org/10.1007/s00018-020-03656-y, doi:10.1007/s00018-020-03656-y. This article has 1797 citations.

  24. (sharygin2023roleofcd14 pages 6-8): Daniel Sharygin, Leonidas G. Koniaris, Clark Wells, Teresa A. Zimmers, and Tewfik Hamidi. Role of cd14 in human disease. Immunology, 169:260-270, Mar 2023. URL: https://doi.org/10.1111/imm.13634, doi:10.1111/imm.13634. This article has 168 citations and is from a peer-reviewed journal.

  25. (sharygin2023roleofcd14 pages 9-10): Daniel Sharygin, Leonidas G. Koniaris, Clark Wells, Teresa A. Zimmers, and Tewfik Hamidi. Role of cd14 in human disease. Immunology, 169:260-270, Mar 2023. URL: https://doi.org/10.1111/imm.13634, doi:10.1111/imm.13634. This article has 168 citations and is from a peer-reviewed journal.

  26. (sharygin2023roleofcd14 pages 4-6): Daniel Sharygin, Leonidas G. Koniaris, Clark Wells, Teresa A. Zimmers, and Tewfik Hamidi. Role of cd14 in human disease. Immunology, 169:260-270, Mar 2023. URL: https://doi.org/10.1111/imm.13634, doi:10.1111/imm.13634. This article has 168 citations and is from a peer-reviewed journal.

Artifacts

Citations

  1. matveichuk2024flotillinsaffectlpsinduced pages 17-20
  2. gauthier2022lipopolysaccharidedetectionby pages 4-5
  3. gauthier2022lipopolysaccharidedetectionby pages 3-4
  4. fitzgerald2020tolllikereceptorsand pages 3-4
  5. behzadi2021tolllikereceptorsgeneral pages 18-19
  6. matveichuk2024flotillinsaffectlpsinduced pages 1-2
  7. stierschneider2023sheddinglighton pages 2-4
  8. duan2022tolllikereceptorsignaling pages 2-3
  9. https://doi.org/10.1111/imm.13634,
  10. https://doi.org/10.1016/j.celrep.2022.110755,
  11. https://doi.org/10.1007/s00018-020-03656-y,
  12. https://doi.org/10.1098/rsob.220146,
  13. https://doi.org/10.1016/j.cell.2020.02.041,
  14. https://doi.org/10.1155/2021/9914854,
  15. https://doi.org/10.1007/s00018-024-05221-3,
  16. https://doi.org/10.3389/fimmu.2023.1264889,
  17. https://doi.org/10.3389/fimmu.2022.812774,